Treatment with magnesium sulphate in pre-term birth: A systematic review and meta-analysis of observational studies

References

• Boyle CA, Yeargin-Allsopp M, Schendel DE, Holmgreen P, Oakley GP. 2000. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. American Journal of Epidemiology 152:120–124.
   PubMed Web of Science ®Google Scholar
• Cahill AG, Caughey AB. 2009. Magnesium for neuroprophylaxis: fact or fiction? American Journal of Obstetrics and Gynecology 200:590–594.
   PubMed Web of Science ®Google Scholar
• Canterino JC, Verma UL, Visintainer PF, Figueroa R, Klein SA, Tejani NA. 1999. Maternal magnesium sulfate and the development of neonatal periventricular leukomalacia and intraventricular hemorrhage. Obstetrics and Gynecology 93:396–402.
   PubMed Web of Science ®Google Scholar
• Cochrane Collaboration. 2010. Cochrane Handbook for Systematic Reviews of Interventions. Available at: www.cochrane.org/resources/handbook. (Updated 1 September 2010) (Accessed 1 October 2010).
   Google Scholar
• Crowther CA, Hiller JE, Doyle LW. 2002. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews (4):CD001060.
   Google Scholar
• Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. 2009. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews (1):CD004661.
   Google Scholar
• Duley L, Gulmezoglu AM, Chou D. 2010. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews (9):CD002960.
   Google Scholar
• Elimian A, Verma R, Ogburn P, Wiencek V, Spitzer A, Quirk JG. 2002. Magnesium sulfate and neonatal outcomes of preterm neonates. Journal of Maternal-Fetal and Neonatal Medicine 12:118–122.
   PubMedGoogle Scholar
• Farkouh LJ, Thorp JA, Jones PG, Clark RH, Knox GE. 2001. Antenatal magnesium exposure and neonatal demise. American Journal of Obstetrics and Gynecology 185:869–872.
   PubMed Web of Science ®Google Scholar
• Gathwala G. 2001. Neuronal protection with magnesium. Indian Journal of Pediatrics 68:417–419.
   PubMedGoogle Scholar
• Grether JK, Hoogstrate J, Selvin S, Nelson KB. 1998. Magnesium sulfate tocolysis and risk of neonatal death. American Journal of Obstetrics and Gynecology 178(1 Pt. 1):1–6.
   PubMed Web of Science ®Google Scholar
• Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. 2000. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. American Journal of Obstetrics and Gynecology 183:717–725.
   PubMed Web of Science ®Google Scholar
• Hauth JC, Goldenberg RL, Nelson KB. 1995. Reduction of cerebral palsy with maternal MgSO4 treatment in newborns weighing 500–1000 grams. American Journal of Obstetrics and Gynecology 172(1 Pt 2):419.
   Google Scholar
• Himpens E, Van den Broeck C, Oostra A, Calders P, Vanhaesebrouck P. 2008. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Developmental Medicine and Child Neurology 50:334–340.
   PubMed Web of Science ®Google Scholar
• Huusom L, Secher N, Pryds O, Whitfield K, Gluud C, Brok J. 2011. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants – but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. British Journal of Obstetrics and Gynaecology 118:1–5.
   Google Scholar
• Jazayeri A, Jazayeri MK, Sutkin G. 2003. Tocolysis does not improve neonatal outcome in patients with preterm rupture of membranes. American Journal of Perinatology 20:189–193.
   PubMed Web of Science ®Google Scholar
• Kimberlin DF, Hauth JC, Goldenberg RL, Bottoms SF, Iams JD, Mercer B . 1998. The effect of maternal magnesium sulfate treatment on neonatal morbidity in ≤ 1000-gram infants. American Journal of Perinatology 15:635–641.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Kouno S, Hiroyama Y, Kuraya K, Kamitomo M, Ibara S . 2000. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. European Journal of Obstetrics, Gynecology, and Reproductive Biology 91:159–164.
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE . 2002. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American Journal of Obstetrics and Gynecology 186:1111–1118.
   PubMed Web of Science ®Google Scholar
• Nelson KB, Grether JK. 1995. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95:263–269.
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. 2006. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews (3):CD004454.
   Google Scholar
• Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. 1996. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. Journal of the American Medical Association 276:1805–1810.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D . 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association 283: 2008–2012.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M . 2009. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis. Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed 1 October 2010).
   Google Scholar